A comparison of top Indian mid-cap mutual funds reveals sharply differing portfolio choices, from sector allocations to market-cap tilts, highlighting the diverse investment approaches within the category.
Among India’s mid-cap mutual funds, the broad label masks very different portfolio choices. A comparison of Edelweiss, HSBC, Invesco and WhiteOak shows that HSBC held the most equity at 98.8%, while Invesco followed at 97%, WhiteOak at 96.8% and Edelweiss at 96.7%. The rest of each portfolio was split in different ways between debt, cash and, in WhiteOak’s case, a small allocation to real estate investment trusts and infrastructure investment trusts.
The sharpest contrast is in market-cap positioning. WhiteOak has the strongest tilt towards smaller companies, with only 6% of equity in large caps, 72% in mid-caps and 22% in small caps. Edelweiss is more cautious by comparison, with 19% in large caps, 69% in mid-caps and 12% in small caps. HSBC and Invesco sit between those two approaches, with HSBC at 10% large caps, 68% mid-caps and 22% small caps, and Invesco at 17%, 63% and 20% respectively.
One stock links all four funds: Federal Bank appears in each of their top 10 holdings. Its weight ranges from 2.8% in WhiteOak to 6.4% in Invesco, with HSBC at 4.9% and Edelweiss at 4%. Beyond that shared position, the funds diverge significantly. Edelweiss has meaningful stakes in BSE and the Multi Commodity Exchange, while HSBC leans on newer-age names such as Lenskart Solutions and FSN E-Commerce Ventures. Invesco is more concentrated at the top, with Prestige Estates Projects as its largest holding, and WhiteOak’s leading positions include Max Financial Services and Bharti Hexacom.
Sector exposure also highlights the different investment styles. Edelweiss has its heaviest weighting in banks, followed by capital markets and auto components. HSBC’s largest allocation is to electrical equipment, then retailing and banks. Invesco is most exposed to retailing, banks and healthcare services, while WhiteOak has the biggest bet on pharmaceuticals and biotechnology, followed by finance and banks. Business Today’s comparison shows that India’s mid-cap fund category is less a single strategy than a collection of distinct bets on size, sector and stock selection.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
